Psychotic Disorders - Germany | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$152.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.15%, resulting in a market volume of US$153.50m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$164.80 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Germany is experiencing significant growth and development.

Customer preferences: In Germany, there is a growing demand for effective treatments and therapies for psychotic disorders. Customers are increasingly seeking personalized and targeted solutions that address their specific symptoms and needs. They are also looking for treatments that have minimal side effects and can be integrated into their daily lives. Additionally, there is a rising interest in alternative and complementary therapies, such as mindfulness and yoga, as a way to manage symptoms and improve overall well-being.

Trends in the market: One major trend in the Psychotic Disorders market in Germany is the shift towards a more holistic approach to treatment. Healthcare providers are recognizing the importance of addressing not only the symptoms of psychotic disorders, but also the underlying causes and contributing factors. This has led to an increased focus on early intervention, psychosocial support, and lifestyle modifications. Furthermore, there is a growing emphasis on integrating mental health services into primary care settings, making treatment more accessible and convenient for patients.Another trend in the market is the adoption of digital health technologies. Germany has a well-developed healthcare system and a high level of digital literacy among its population. This has created opportunities for the use of telemedicine, mobile applications, and online platforms to deliver mental health services and support. These technologies offer convenience, anonymity, and the ability to reach individuals in remote or underserved areas. They also provide opportunities for remote monitoring and data collection, which can help improve treatment outcomes and personalize care.

Local special circumstances: Germany has a strong healthcare infrastructure and a well-established network of mental health professionals. The country has a universal healthcare system, which ensures that individuals have access to necessary treatments and therapies for psychotic disorders. Additionally, Germany has a robust research and development sector, which fosters innovation and drives advancements in the field of mental health.

Underlying macroeconomic factors: The growth and development of the Psychotic Disorders market in Germany can be attributed to several underlying macroeconomic factors. Firstly, there is an increasing awareness and recognition of mental health issues in society, leading to a greater demand for services and treatments. Secondly, there is a growing aging population in Germany, which is associated with a higher risk of developing psychotic disorders. Finally, the COVID-19 pandemic has had a significant impact on mental health globally, including in Germany. The pandemic has highlighted the importance of mental health and has spurred investment and innovation in the field.Overall, the Psychotic Disorders market in Germany is experiencing growth and development due to customer preferences for personalized and holistic treatments, as well as the adoption of digital health technologies. The country's strong healthcare infrastructure and research sector, coupled with underlying macroeconomic factors, have created a favorable environment for advancements in the field of mental health.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.